Cyclic interferon gamma application in patients with renal cell carcinoma.
Grups
J W
JW
Department of Urology, School of Medicine, University of Würzburg, FRG.
Frohmüller
H G
HG
D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000627:therapeutic use; D007371:Interferon-gamma / Q000008:administration & dosage* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D007694:Killer Cells, Natural / Q000276:immunology; D007958:Leukocyte Count; D009392:Nephrectomy; D011994:Recombinant Proteins; D013601:T-Lymphocytes / Q000473:pathology
D007155:Immunologic Factors; D011994:Recombinant Proteins; D007371:Interferon-gamma